Phase 1 safety and pharmacokinetics of ALK001 in people over 60
Ended Project Grant Awarded Last action
- Award ID
- R41EY021988
- Recipient
-
Alkeus Pharmaceuticals Inc. UEI MQZNHQ1FW6M3
- Awarding agency
-
National Institutes of Health
Department of Health and Human Services
- Obligated
- $165,198
Award facts
- Assistance listing
- 93.867 Vision Research
- Completion date
- Originally
- Funding agency
- Department of Health and Human Services
- Place of performance
- Cambridge, MA 02140, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | -$1 | |
| Original award | $165,199 |
Quick answers
Who received award R41EY021988?
R41EY021988 was awarded to Alkeus Pharmaceuticals Inc. by National Institutes of Health (Department of Health and Human Services) on September 1, 2012.
How much is award R41EY021988 worth?
$165,198 has been obligated on R41EY021988.
Which agency awarded R41EY021988?
National Institutes of Health (Department of Health and Human Services) awarded R41EY021988, with funding from Department of Health and Human Services.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award